Even though histologic evaluation remains necessary for differentiating these tumors from other tumor subtypes (e.g., astrocytoma, metastasis, lymphomas, etc.)and for detecting N-Myc amplification, neuroimaging (above all MRI) retains a pivotal role in defining tumor site, recurrence, or dissemination and in surgical planning. The gene discussed is MYCN; the disease is neoplasm.